iBio
IBIO
#10251
Rank
C$83.36 M
Marketcap
C$1.68
Share price
0.85%
Change (1 day)
43.48%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): C-$1.06

According to iBio's latest financial reports the company's current EPS (TTM) is C-$1.07. In 2025 the company made an earnings per share (EPS) of C-$2.49 an increase over its 2024 EPS that were of C-$9.24.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.06-57.21%
2025C-$2.49-73.08%
2024C-$9.24-93.88%
2023C-$151.02-8.14%
2022C-$164.4092.67%
2021C-$85.33-80.33%
2020C-$433.76-35.11%
2019C-$668.42-38.96%
2018C-$1,095-6.1%
2017C-$1,16636.67%
2016C-$853.3033.33%
2015C-$639.9850%
2014C-$426.65-53.85%
2013C-$924.41-7.14%
2012C-$995.52-64.1%
2011C-$2,77377.27%
2010C-$1,564144.44%
2009C-$639.9812.93%
2008C-$566.7112.2%
2007C-$505.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.42-1,264.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
C-$0.74-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
C-$9.53 793.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C-$4.89 358.67%๐Ÿ‡บ๐Ÿ‡ธ USA